Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/UCB.BR

UCB.BR

UCB SA

Healthcare - BE

UCB SA is a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines and solutions for people living with severe neurological and immunology diseases. The company operates through…

HQ: Brussels, BU, Belgiumwww.ucb.com

EUR201.70-1.42%vs prev. close

Market snapshot

Price

EUR201.70

Daily move

-1.42%

P/E

18.2

EPS TTM

11.32

Dividend yield

0.72%

Beta

0.18

Market cap

45.5B

Price history

UCB.BR price

EUR

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
UCB	UCB.BR	Biotechnology	45.5	18.2	0.72%	-8.6%	-10.8%	-25.6%	-20.1%	-3.2%	-15.5%

Subscribe to Equity Analytics to compare UCB.BR with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.